Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumor, Adult × Classical hematology × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 34 Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 140 Anemia 138 Myelodysplastic Syndromes 134 Leukemia 132 Leukemia, Myeloid, Acute 126 Neoplasms 110 Leukemia, Myelomonocytic, Chronic 98 Precursor Cell Lymphoblastic Leukemia-Lymphoma 96 Multiple Myeloma 78 Myeloproliferative Disorders 74 Leukemia, Lymphocytic, Chronic, B-Cell 72 Lymphoma, Non-Hodgkin 61 Venous Thromboembolism 59 Hodgkin Disease 58 Anemia, Refractory 57 Thrombocytopenia 55 Blast Crisis 52 Lymphoma 51 Congenital Abnormalities 49 Leukemia, Myeloid, Chronic-Phase 46 Leukemia, Myeloid, Accelerated Phase 45 Lymphoma, Follicular 41 Myelodysplastic-Myeloproliferative Diseases 40 Anemia, Aplastic 39 Primary Myelofibrosis 37 Febrile Neutropenia 37 Lymphoma, Mantle-Cell 36 Neutropenia 35 Neoplasms, Plasma Cell 34 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03656172 2021-04-21

RET-HE

Institut Cancerologie de l'Ouest

Classical hematologyOther solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡